Adjuvant Global Health Technology Fund, L.P.
Related Filers (4)
- AN2 Therapeutics, Inc. (15)
- Adjuvant Global Health Technology Fund DE, L.P. (12)
- Adjuvant Capital GP, L.P. (10)
- Adjuvant Capital Management, LLC (10)
- Show More ...
Other (4)
144
Tuesday, 1/16/2024
Filing for proposed sale of securities under Rule 144
D/A
Tuesday, 2/23/2021
Exempt (Private) Offering
D/A
Friday, 1/17/2020
Exempt (Private) Offering
D
Monday, 8/5/2019
Exempt (Private) Offering
Ownership (14)
SC 13G/A
Friday, 2/9/2024
AN2 Therapeutics, Inc.: Major Shareholders
4
Thursday, 1/18/2024
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/16/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/3/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/29/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/15/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/8/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/25/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/10/2023
AN2 Therapeutics, Inc.: Major Shareholders
4
Friday, 6/24/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 6/24/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3/A
Friday, 6/24/2022
AN2 Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 3/31/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/24/2022
AN2 Therapeutics, Inc.: Initial statement of beneficial ownership of securities